Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Merck & Co., Inc.

MRK Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

$MRK stock is featured in our U.S. House Long-Short, Congress Buys, and Congress Long-Short strategies.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of MRK by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 24, 2026
Maria Elvira Salazar House / R Purchase $15,001 - $50,000 Aug 19, 2026
Maria Elvira Salazar House / R Purchase $15,001 - $50,000 Aug 19, 2026
Ro Khanna House / D Purchase $15,001 - $50,000 Aug 07, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 08, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 16, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 02, 2026
Ro Khanna House / D Sale $15,001 - $50,000 May 15, 2026
Alan Armstrong Senate / R Sale (Full) $15,001 - $50,000 Mar 27, 2026
Ro Khanna House / D Purchase $15,001 - $50,000 Mar 10, 2026
Josh Gottheimer House / D Purchase $1,001 - $15,000 Feb 04, 2026
Michael T. McCaul House / R Sale $15,001 - $50,000 Jan 13, 2026
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Dec 19, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Dec 18, 2025
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Nov 18, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Nov 13, 2025
Michael T. McCaul House / R Sale $15,001 - $50,000 Oct 27, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 29, 2025
Val T. Hoyle House / D Sale $1,001 - $15,000 Sep 23, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Aug 28, 2025
Michael T. McCaul House / R Sale $50,001 - $100,000 Aug 22, 2025
Michael T. McCaul House / R Sale $50,001 - $100,000 Aug 22, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Aug 14, 2025
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Aug 05, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ritchie Torres House / D Sale $1,001 - $15,000 Jul 11, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 01, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 01, 2025
Michael T. McCaul House / R Sale $100,001 - $250,000 Jun 27, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jun 24, 2025
Ro Khanna House / D Purchase $15,001 - $50,000 Jun 23, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 20, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 20, 2025
Scott Franklin House / R Sale $1,001 - $15,000 Jun 16, 2025
Julie Johnson House / D Purchase $1,001 - $15,000 Jun 13, 2025
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 May 30, 2025
Ro Khanna House / D Purchase $15,001 - $50,000 May 28, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 19, 2025
Michael T. McCaul House / R Purchase $50,001 - $100,000 May 19, 2025
Robert Bresnahan House / R Sale $15,001 - $50,000 May 15, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 09, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 08, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 May 05, 2025
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Apr 29, 2025
Ro Khanna House / D Sale $15,001 - $50,000 Apr 23, 2025
Bruce Westerman House / R Sale $1,001 - $15,000 Apr 21, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 Apr 17, 2025
Ro Khanna House / D Purchase $15,001 - $50,000 Apr 15, 2025
MRK Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
MRK Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MRK Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in MRK holdings by institutional investors

Quarterly net insider trading by MRK's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $2,270,000 Jul 20, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Animals
  • $4,150,000 Apr 20, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Animals
  • $1,930,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Animals
  • $4,990,000 Oct 20, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Animals
  • $1,520,000 Oct 20, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Animals
  • $1,800,000 Apr 21, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $2,600,000 Apr 21, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Animals
  • $2,190,000 Oct 21, 2024 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $3,010,000 Jul 22, 2024 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $1,940,000 Jan 22, 2024 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,130,000 Oct 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,980,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,490,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $1,080,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,610,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,120,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $1,500,000 Jan 20, 2022 Issue: None
  • $1,700,000 Oct 20, 2021 Issue: None
  • $1,220,000 Jul 20, 2021 Issue: None
  • $3,590,000 Apr 20, 2021 Issue: None
  • $1,210,000 Jan 21, 2021 Issue: None
  • $980,000 Oct 20, 2020 Issue: None
  • $2,620,000 Jul 20, 2020 Issue: None
  • $2,170,000 Apr 20, 2020 Issue: None
  • $1,020,000 Jan 22, 2020 Issue: None
  • $890,000 Oct 21, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Agriculture Taxation/Internal Revenue Code
  • $2,305,000 Jul 22, 2019 Issue: Health Issues Agriculture Medicare/Medicaid Consumer Issues/Safety/Products Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $2,740,000 Apr 22, 2019 Issue: Intelligence Animals Medicare/Medicaid Health Issues Agriculture Taxation/Internal Revenue Code
  • $900,000 Jan 22, 2019 Issue: Medicare/Medicaid Health Issues Animals Taxation/Internal Revenue Code
  • $1,760,000 Oct 22, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Animals Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $830,000 Jul 20, 2018 Issue: Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Budget/Appropriations
  • $3,310,000 Apr 20, 2018 Issue: Animals Budget/Appropriations Medicare/Medicaid Health Issues
  • $790,000 Jan 22, 2018 Issue: Animals Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Budget/Appropriations
  • $1,750,000 Oct 20, 2017 Issue: Budget/Appropriations Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $1,720,000 Jul 20, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Animals Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $1,970,000 Jul 20, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $1,000,000 Jan 23, 2017 Issue: Animals Budget/Appropriations Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $1,390,000 Oct 20, 2016 Issue: Animals Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $850,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Animals Trade (domestic/foreign) Budget/Appropriations
  • $3,260,000 Apr 20, 2016 Issue: Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues Animals
  • $650,000 Jan 20, 2016 Issue: Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues Budget/Appropriations Animals
  • $1,490,000 Oct 19, 2015 Issue: Animals Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $1,400,000 Jul 20, 2015 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $2,110,000 Apr 20, 2015 Issue: Animals Budget/Appropriations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
  • $490,000 Mar 25, 2015 Issue: Animals Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $1,160,000 Oct 20, 2014 Issue: Animals Health Issues Copyright/Patent/Trademark Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $1,170,000 Jul 21, 2014 Issue: Animals Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations
  • $2,000,000 Apr 21, 2014 Issue: Budget/Appropriations Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Copyright/Patent/Trademark Animals
  • $820,000 Jan 17, 2014 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Taxation/Internal Revenue Code Manufacturing Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues
  • $2,890,000 Oct 21, 2013 Issue: Animals Consumer Issues/Safety/Products Medicare/Medicaid Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Health Issues Trade (domestic/foreign) Manufacturing
  • $1,420,000 Oct 21, 2013 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Manufacturing
  • $900,000 Jul 22, 2013 Issue: Animals Consumer Issues/Safety/Products Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Budget/Appropriations Health Issues Manufacturing
  • $1,190,000 Jan 18, 2013 Issue: Medical/Disease Research/Clinical Labs Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Manufacturing
  • $2,430,000 Oct 19, 2012 Issue: Health Issues Taxation/Internal Revenue Code Manufacturing Medicare/Medicaid Medical/Disease Research/Clinical Labs Trade (domestic/foreign) Budget/Appropriations Consumer Issues/Safety/Products
  • $1,400,000 Jul 19, 2012 Issue: Consumer Issues/Safety/Products Health Issues Taxation/Internal Revenue Code Manufacturing Trade (domestic/foreign) Medicare/Medicaid
  • $4,490,000 Apr 20, 2012 Issue: Law Enforcement/Crime/Criminal Justice Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Manufacturing Trade (domestic/foreign) Consumer Issues/Safety/Products
  • $1,120,000 Jan 20, 2012 Issue: Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Manufacturing Law Enforcement/Crime/Criminal Justice Budget/Appropriations Consumer Issues/Safety/Products
  • $2,450,000 Oct 20, 2011 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Animals Law Enforcement/Crime/Criminal Justice Trade (domestic/foreign) Copyright/Patent/Trademark
  • $1,120,000 Jul 20, 2011 Issue: Budget/Appropriations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Consumer Issues/Safety/Products Medicare/Medicaid
  • $3,220,000 May 17, 2011 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid Budget/Appropriations Financial Institutions/Investments/Securities Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $1,285,000 Jan 20, 2011 Issue: Consumer Issues/Safety/Products Chemicals/Chemical Industry Budget/Appropriations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
  • $2,163,510 Oct 20, 2010 Issue: Animals Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Consumer Issues/Safety/Products Chemicals/Chemical Industry
  • $944,000 Jul 20, 2010 Issue: Animals Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Financial Institutions/Investments/Securities Chemicals/Chemical Industry Taxation/Internal Revenue Code
  • $3,220,000 Apr 19, 2010 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Financial Institutions/Investments/Securities Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $1,820,000 Jan 20, 2010 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $1,560,000 Oct 20, 2009 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Budget/Appropriations
  • $1,530,000 Jul 20, 2009 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $1,500,000 Apr 20, 2009 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $1,320,000 Jan 21, 2009 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $1,110,000 Oct 17, 2008 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $1,170,000 Jul 18, 2008 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations
  • $1,040,000 Apr 18, 2008 Issue: Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Medicare/Medicaid Budget/Appropriations
  • $2,530,000 Feb 13, 2008 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $2,300,000 Aug 13, 2007 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $1,980,000 Feb 14, 2007 Issue: Health Issues Medicare/Medicaid Budget/Appropriations Taxation/Internal Revenue Code
  • $2,070,000 Aug 11, 2006 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Budget/Appropriations
  • $1,980,000 Feb 09, 2006 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $1,700,000 Aug 15, 2005 Issue: Trade (domestic/foreign) Medicare/Medicaid Consumer Issues/Safety/Products
  • $1,820,000 Feb 14, 2005 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Consumer Issues/Safety/Products
  • $1,740,000 Aug 16, 2004 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Consumer Issues/Safety/Products
  • $3,040,000 Feb 27, 2004 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Consumer Issues/Safety/Products
  • $4,420,000 Aug 19, 2003 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Homeland Security
  • $4,670,294 Feb 14, 2003 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $2,660,000 Aug 20, 2002 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Medicare/Medicaid Environment/Superfund Medical/Disease Research/Clinical Labs
  • $3,420 Jul 24, 2002 Issue: Trade (domestic/foreign) Disaster Planning/Emergencies Health Issues Veterans Medicare/Medicaid Budget/Appropriations Environment/Superfund Medical/Disease Research/Clinical Labs
  • $2,780,000 Aug 09, 2001 Issue: Budget/Appropriations Environment/Superfund Trade (domestic/foreign) Manufacturing Taxation/Internal Revenue Code Health Issues Veterans Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $2,820,000 Feb 14, 2001 Issue: Trade (domestic/foreign) Manufacturing Taxation/Internal Revenue Code Health Issues Veterans Medicare/Medicaid Budget/Appropriations Environment/Superfund Medical/Disease Research/Clinical Labs
  • $302,000 Aug 14, 2000 Issue: Trade (domestic/foreign) Manufacturing Taxation/Internal Revenue Code Health Issues Veterans Medicare/Medicaid Budget/Appropriations Environment/Superfund Medical/Disease Research/Clinical Labs
  • $2,600,000 Feb 14, 2000 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Environment/Superfund Pharmacy Trade (domestic/foreign) Manufacturing Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Veterans Medicare/Medicaid
  • $2,720,000 Aug 16, 1999 Issue: Trade (domestic/foreign) Manufacturing Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Veterans Medicare/Medicaid Budget/Appropriations Environment/Superfund Pharmacy Medical/Disease Research/Clinical Labs

Former government officials who have lobbied for MRK

105 former government officials from 56 congressional offices at 23 lobbying firms have lobbied for MRK, most recently Jul 21, 2026.

  • Raissa Downs Senate Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte. Formerly HELP Cmte. · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Jennifer Young Congress Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance Formerly Cmte. on Finance · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Steny H. Hoyer
    Elizabeth Murray House Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham Formerly with Steny H. Hoyer · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Jim DeMint
    Charlotte Ivancic Senate Legislative Counsel, Senator Jim DeMint; Health Counsel, Majority Leader Bill Frist; Counsel and Budget Analyst, House Budget Committee; Asst. to the Speaker for Policy, Speaker John Boehner Formerly with Jim DeMint · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Tom Harkin
    Pamela Smith Senate Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun Formerly with Tom Harkin · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Emily Murry House Staff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price Formerly Ken Calvert · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Kyrsten Sinema
    Margaret Joseph Senate CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte. Formerly with Kyrsten Sinema · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Peter Fise Congress Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform Formerly Cmte on Finance · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
See all 105 on the Revolving Door dashboard

MRK Estimated quarterly lobbying spending

MRK Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
MRK Income Statement
MRK Balance Sheet
MRK Cash Flow
U.S. Patents

New MRK patent grants

  • Patent Title: Sample separating implement and sample analyzing device Feb. 16, 2021
  • Patent Title: Biomolecule analyzer Sep. 03, 2019
  • Patent Title: Method of treating inherited severe neutropenia Oct. 09, 2012
  • Patent Title: Tyrosine kinase inhibitors Feb. 22, 2011
  • Patent Title: Substituted piperidines that increase p53 activity and the uses thereof Feb. 08, 2011
  • Patent Title: Process for the preparation of ring compounds Nov. 30, 2010
  • Patent Title: Hiv integrase inhibitors Oct. 26, 2010
  • Patent Title: Process for {3-[2( Oct. 05, 2010
  • Patent Title: Hepatitis c virus assay systems Aug. 31, 2010
  • Patent Title: Anti-addl antibodies and uses thereof Aug. 24, 2010
  • Patent Title: Purification process for plasmid dna Aug. 03, 2010
  • Patent Title: Inhibitors of janus kinases Jul. 27, 2010
  • Patent Title: System and method for automated selection of t-cell epitopes Jul. 13, 2010
  • Patent Title: High affinity antibody antagonists of interleukin-13 receptor alpha 1 Jul. 13, 2010
  • Patent Title: Mitotic kinesin inhibitors Jun. 29, 2010
  • Patent Title: Human antibodies interacting with hiv gp41 Jun. 29, 2010
  • Patent Title: Mitotic kinesin inhibitors Jun. 08, 2010
  • Patent Title: Anti-addl monoclonal antibody and use thereof Jun. 08, 2010
  • Patent Title: Mitotic kinesin inhibitors May. 25, 2010
  • Patent Title: Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease May. 11, 2010
  • Patent Title: Anti-hypercholesterolemic compounds Apr. 27, 2010
  • Patent Title: Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors Apr. 20, 2010
  • Patent Title: Optimized expression of hpv 52 l1 in yeast Apr. 20, 2010
  • Patent Title: Non-immunostimulatory antibody and compositions containing the same Apr. 20, 2010
  • Patent Title: Prodrugs of diaryl-2-(5h)-furanone cyclooxygenase-2 inhibitors Mar. 30, 2010
  • Patent Title: Bicyclic amides Feb. 23, 2010
  • Patent Title: Mitotic kinesin inhibitors Feb. 23, 2010
  • Patent Title: 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists Feb. 09, 2010
  • Patent Title: Computer systems and methods for subdividing a complex disease into component diseases Jan. 26, 2010
  • Patent Title: Cetp inhibitors Jan. 26, 2010
  • Patent Title: Pyrazole amide derivatives, compositions containing such compounds and methods of use Jan. 19, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to MRK from public contracts

MRK News

Recent insights relating to MRK

CNBC Recommendations

Recent picks made for MRK stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MRK

MRK Analyst Ratings

MRK Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
MRK Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $MRK stock a Buy, Sell, or Hold?

  • What is the price target for $MRK stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

MRK Top Shareholders
Shareholder
Shares Held
MRK Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $MRK stock?

  • Who owns the most shares of $MRK stock?

  • What funds own $MRK stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MRK Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MRK Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About MRK

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

  • Address Rahway, NJ
  • Market Cap 365.1 billion
  • Employees 75,000
  • Industrial Classification Pharmaceutical Preparations

Merck & Co., Inc. (MRK) Historical Stock Prices

Merck & Co., Inc. (MRK) closed at $147.98 on September 24, 2026. Over the past year its adjusted close ranged from $75.82 to $156.45. Daily prices go back to January 2, 2014, 3,201 trading days in all.

  • 1 month-5.41%
  • 3 months+17.96%
  • Year to date+42.67%
  • 1 year+90.09%
  • 3 years+52.34%
  • 5 years+132.79%
  • Max+360.41%
See every congressional and insider trade on the MRK price chart

Quiver Premium charts MRK's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 148.16 151.46 147.90 147.98 147.98 10,312,766
Sep 23, 2026 151.31 152.01 146.89 148.08 148.08 9,703,729
Sep 22, 2026 148.69 153.57 148.04 150.91 150.91 11,173,544
Sep 21, 2026 146.78 150.49 145.60 149.50 149.50 7,996,433
Sep 18, 2026 147.08 147.84 145.74 146.87 146.87 31,159,667
Sep 17, 2026 145.74 147.65 145.32 147.15 147.15 11,063,793
Sep 16, 2026 143.96 144.97 143.50 144.91 144.91 7,230,927
Sep 15, 2026$0.85 dividend 143.85 144.15 142.32 143.79 143.79 8,292,750
Sep 14, 2026 146.42 147.09 144.10 144.85 144.85 7,414,159
Sep 11, 2026 145.52 145.90 143.68 143.93 143.93 8,679,443
Sep 10, 2026 147.94 148.00 144.10 144.71 144.71 7,544,530
Sep 9, 2026 148.96 149.41 147.18 147.53 147.53 8,546,447
Sep 8, 2026 148.41 149.60 146.28 148.46 148.46 11,187,297
Sep 4, 2026 150.83 152.22 150.09 150.33 150.33 4,397,467
Sep 3, 2026 152.80 152.80 148.90 152.34 152.34 6,542,969
Sep 2, 2026 151.50 152.69 149.97 151.64 151.64 8,970,603
Sep 1, 2026 150.23 151.68 148.55 149.86 149.86 9,866,566
Aug 31, 2026 147.00 148.69 145.95 147.76 147.76 11,126,604
Aug 28, 2026 146.72 149.01 145.75 148.35 148.35 8,067,848
Aug 27, 2026 149.53 152.08 149.02 149.54 149.54 8,530,989
Aug 26, 2026 154.35 155.19 152.61 153.10 153.10 8,634,975
Aug 25, 2026 151.00 156.92 150.66 156.45 156.45 14,005,080
Aug 24, 2026 150.72 151.52 149.14 150.66 150.66 15,032,010
Aug 21, 2026 149.12 154.49 148.59 152.55 152.55 15,976,212
Aug 20, 2026 150.78 152.51 148.52 148.99 148.99 16,204,664
Aug 19, 2026 146.94 153.50 144.90 152.20 152.20 32,776,268
Aug 18, 2026 137.24 137.98 134.88 135.17 135.17 10,284,238
Aug 17, 2026 134.95 137.17 134.55 135.97 135.97 8,477,590
Aug 14, 2026 134.43 135.97 133.40 135.84 135.84 6,869,004
Aug 13, 2026 133.86 135.68 133.06 135.55 135.55 8,895,212
Aug 12, 2026 130.25 134.06 128.91 132.92 132.92 10,447,088
Aug 11, 2026 129.93 132.84 129.70 130.42 130.42 6,342,169
Aug 10, 2026 128.29 130.98 128.24 130.92 130.92 6,007,618
Aug 7, 2026 127.84 128.75 126.68 128.58 128.58 7,347,555
Aug 6, 2026 130.96 131.08 127.80 128.37 128.37 7,052,064
Aug 5, 2026 129.41 131.09 127.56 128.33 128.33 10,501,869
Aug 4, 2026 128.46 129.99 126.22 128.00 128.00 11,816,856
Aug 3, 2026 129.87 131.47 126.72 127.77 127.77 11,153,829
Jul 31, 2026 128.92 131.04 128.14 130.20 130.20 7,738,762
Jul 30, 2026 128.19 130.21 127.25 129.79 129.79 7,833,237
Jul 29, 2026 132.37 132.69 129.65 130.36 130.36 7,539,454
Jul 28, 2026 132.88 135.05 131.14 131.82 131.82 10,265,058
Jul 27, 2026 131.01 132.53 130.45 130.76 130.76 6,910,338
Jul 24, 2026 131.44 131.71 130.24 131.07 131.07 6,154,380
Jul 23, 2026 127.82 131.04 127.82 130.48 130.48 8,531,273
Jul 22, 2026 127.32 128.83 126.62 127.47 127.47 7,792,422
Jul 21, 2026 124.80 126.77 124.09 126.26 126.26 7,344,785
Jul 20, 2026 127.28 127.89 124.22 124.40 124.40 7,729,047
Jul 17, 2026 128.45 131.74 127.03 127.50 127.50 13,472,722
Jul 16, 2026 124.33 128.93 124.00 127.63 127.63 13,038,762
Jul 15, 2026 124.25 124.90 122.75 123.61 123.61 9,053,781
Jul 14, 2026 123.30 123.66 120.16 120.78 120.78 9,932,947
Jul 13, 2026 123.58 124.74 122.44 124.03 124.03 5,225,798
Jul 10, 2026 125.12 125.56 122.90 123.54 123.54 8,388,685
Jul 9, 2026 125.48 128.07 124.44 125.07 125.07 6,975,495
Jul 8, 2026 128.34 128.99 125.14 125.99 125.99 7,910,217
Jul 7, 2026 128.77 129.69 127.89 128.86 128.86 10,174,349
Jul 6, 2026 129.31 130.00 125.62 126.78 126.78 9,499,257
Jul 2, 2026 126.17 129.61 125.99 129.56 129.56 7,833,991
Jul 1, 2026 128.01 128.42 124.71 125.37 125.37 10,761,469
Jun 30, 2026 129.22 130.29 126.68 128.50 128.50 11,837,216
Jun 29, 2026 127.64 129.97 126.74 129.38 129.38 9,584,596
Jun 26, 2026 125.83 128.78 125.83 128.66 128.66 18,891,534
Jun 25, 2026 121.63 125.96 121.00 125.45 125.45 14,049,625
Jun 24, 2026 120.90 121.81 119.51 120.60 120.60 10,478,132
Jun 23, 2026 116.53 119.80 116.53 119.60 119.60 10,469,255
Jun 22, 2026 113.97 115.63 113.00 115.48 115.48 10,521,233
Jun 18, 2026 114.64 114.94 111.57 113.87 113.87 29,521,620
Jun 17, 2026 114.86 115.99 114.02 115.44 115.44 10,459,874
Jun 16, 2026 115.88 115.90 113.57 115.17 115.17 10,665,445
Jun 15, 2026$0.85 dividend 118.71 118.95 114.86 114.90 114.90 15,395,716
Jun 12, 2026 121.50 121.90 118.83 119.05 118.18 10,927,107
Jun 11, 2026 120.04 122.71 119.95 120.76 119.87 13,180,276
Jun 10, 2026 119.78 120.04 117.26 119.09 118.22 10,302,107
Jun 9, 2026 120.03 120.50 118.00 119.60 118.72 9,669,142
Jun 8, 2026 120.85 122.60 118.69 119.52 118.64 12,312,220
Jun 5, 2026 120.94 123.46 120.36 120.79 119.90 15,967,214
Jun 4, 2026 117.16 120.55 117.09 120.26 119.38 15,933,945
Jun 3, 2026 115.44 117.33 114.70 114.70 113.86 8,225,149
Jun 2, 2026 114.50 116.78 114.50 115.65 114.80 8,311,471
Jun 1, 2026 117.55 117.96 114.36 115.17 114.32 9,406,727
May 29, 2026 119.65 120.67 118.19 118.72 117.85 16,599,390
May 28, 2026 120.26 121.50 119.36 119.89 119.01 9,260,174
May 27, 2026 119.82 122.40 119.78 120.24 119.36 7,163,192
May 26, 2026 122.90 123.13 119.41 119.72 118.84 10,012,129
May 22, 2026 120.55 122.66 120.08 122.41 121.51 14,754,581
May 21, 2026 112.79 115.98 112.09 115.88 115.03 7,402,732
May 20, 2026 114.63 114.95 112.90 113.00 112.17 9,130,578
May 19, 2026 112.56 115.10 112.13 114.24 113.40 7,555,354
May 18, 2026 111.43 112.89 110.97 112.56 111.73 8,047,204
May 15, 2026 113.90 113.93 110.94 111.38 110.56 10,028,864
May 14, 2026 113.63 113.90 112.56 113.41 112.58 5,284,176
May 13, 2026 112.25 114.06 112.04 113.45 112.62 8,110,464
May 12, 2026 111.50 113.69 111.39 112.37 111.55 9,117,391
May 11, 2026 112.15 113.68 111.01 111.28 110.46 7,750,595
May 8, 2026 112.38 113.01 111.18 111.38 110.56 5,725,143
May 7, 2026 113.51 113.75 111.10 112.30 111.47 7,329,028
May 6, 2026 113.15 114.48 112.74 113.56 112.73 7,256,078
May 5, 2026 113.67 114.07 112.83 113.15 112.32 7,910,399
May 4, 2026 111.41 114.62 110.75 113.11 112.28 7,659,082
May 1, 2026 112.33 114.54 111.88 112.16 111.34 11,953,717
Apr 30, 2026 109.34 112.24 108.63 109.18 108.38 17,131,228
Apr 29, 2026 108.55 111.22 107.90 110.95 110.14 9,769,879
Apr 28, 2026 111.52 111.91 109.70 110.03 109.22 7,157,568
Apr 27, 2026 111.22 112.75 110.14 110.23 109.42 9,133,637
Apr 24, 2026 113.74 114.03 111.50 111.90 111.08 7,060,014
Apr 23, 2026 113.36 115.02 113.10 114.62 113.78 6,826,250
Apr 22, 2026 112.61 113.51 111.54 112.89 112.06 8,037,515
Apr 21, 2026 116.49 116.53 111.91 112.56 111.73 12,769,519
Apr 20, 2026 119.15 119.36 116.75 117.10 116.24 7,392,032
Apr 17, 2026 115.56 119.20 115.56 119.07 118.20 16,194,901
Apr 16, 2026 117.13 117.85 114.71 115.46 114.61 11,399,886
Apr 15, 2026 119.80 120.25 116.64 117.90 117.03 7,689,371
Apr 14, 2026 119.03 120.36 118.15 119.96 119.08 12,449,439
Apr 13, 2026 121.03 121.30 119.06 120.15 119.27 6,357,339
Apr 10, 2026 122.96 123.01 120.95 121.42 120.53 9,706,972
Apr 9, 2026 122.90 124.00 121.35 122.68 121.78 8,666,348
Apr 8, 2026 119.60 123.63 117.94 123.18 122.28 9,256,857
Apr 7, 2026 119.56 119.56 116.50 119.28 118.40 11,376,365
Apr 6, 2026 120.41 121.48 120.04 120.85 119.96 4,890,475
Apr 2, 2026 120.37 121.65 119.22 120.87 119.98 6,387,888
Apr 1, 2026 120.88 122.19 120.27 120.84 119.95 6,351,678
Mar 31, 2026 119.03 121.27 118.77 120.29 119.41 10,713,334
Mar 30, 2026 120.56 121.64 117.22 118.10 117.23 11,083,960
Mar 27, 2026 119.28 121.07 118.60 119.63 118.75 8,345,762
Mar 26, 2026 118.95 120.06 118.65 118.93 118.06 6,497,238
Mar 25, 2026 117.30 120.12 116.80 119.37 118.49 10,220,314
Mar 24, 2026 114.70 116.54 114.02 116.37 115.52 7,411,878
Mar 23, 2026 116.17 116.47 114.77 115.68 114.83 9,096,367
Mar 20, 2026 114.25 115.18 112.72 114.18 113.34 36,355,421
Mar 19, 2026 114.66 115.76 113.75 114.20 113.36 8,383,761
Mar 18, 2026 115.06 115.56 113.34 114.50 113.66 6,736,269
Mar 17, 2026 115.78 116.80 114.38 115.87 115.02 7,952,157
Mar 16, 2026$0.85 dividend 115.34 116.06 114.22 115.43 114.58 8,785,305
Mar 13, 2026 116.92 117.89 115.53 115.61 113.92 7,111,035
Mar 12, 2026 115.47 116.60 114.30 115.91 114.22 8,349,180
Mar 11, 2026 116.76 116.95 115.28 116.21 114.51 6,769,631
Mar 10, 2026 117.24 119.00 116.67 117.09 115.38 9,739,257
Mar 9, 2026 114.98 117.26 114.11 117.11 115.40 8,321,571
Mar 6, 2026 115.16 116.36 113.82 115.79 114.10 12,809,312
Mar 5, 2026 119.11 119.53 114.45 116.07 114.38 14,524,747
Mar 4, 2026 119.43 120.87 117.86 120.28 118.52 6,700,910
Mar 3, 2026 119.67 120.97 118.61 119.83 118.08 9,334,139
Mar 2, 2026 123.51 123.70 121.04 121.41 119.64 11,564,486
Feb 27, 2026 119.68 124.00 119.68 123.82 122.01 17,636,440
Feb 26, 2026 122.40 122.50 119.00 119.30 117.56 10,327,287
Feb 25, 2026 124.01 125.14 122.26 122.46 120.67 11,082,461
Feb 24, 2026 123.41 124.84 122.63 123.93 122.12 8,460,699
Feb 23, 2026 122.31 124.19 121.50 123.82 122.01 9,661,094
Feb 20, 2026 122.64 122.69 120.60 122.26 120.47 9,442,855
Feb 19, 2026 121.40 122.60 120.50 121.86 120.08 8,933,309
Feb 18, 2026 121.25 121.81 120.39 121.66 119.88 7,803,418
Feb 17, 2026 122.36 123.08 120.80 121.57 119.80 9,899,761
Feb 13, 2026 121.50 123.33 121.03 121.41 119.64 10,102,324
Feb 12, 2026 119.01 121.61 118.12 119.24 117.50 13,453,271
Feb 11, 2026 117.04 119.36 116.31 119.31 117.57 10,885,294
Feb 10, 2026 117.69 118.18 116.10 117.15 115.44 11,849,545
Feb 9, 2026 121.41 121.88 116.98 117.65 115.93 16,158,727
Feb 6, 2026 120.76 122.66 120.44 121.93 120.15 13,083,323
Feb 5, 2026 118.31 122.43 118.31 119.75 118.00 24,010,554
Feb 4, 2026 116.90 120.39 116.50 118.33 116.60 21,954,563
Feb 3, 2026 111.67 118.46 111.44 115.84 114.15 25,793,563
Feb 2, 2026 110.12 113.89 109.95 113.37 111.72 18,000,106
Jan 30, 2026 108.59 110.53 107.95 110.27 108.66 19,060,604
Jan 29, 2026 107.33 109.93 107.10 108.34 106.76 13,572,813
Jan 28, 2026 106.85 107.93 106.03 106.90 105.34 7,491,691
Jan 27, 2026 107.50 108.35 106.84 107.92 106.34 7,907,088
Jan 26, 2026 107.80 108.42 107.06 107.40 105.83 9,903,240
Jan 23, 2026 109.09 109.09 107.21 108.18 106.60 10,489,492
Jan 22, 2026 110.78 111.32 108.58 109.18 107.59 9,362,585
Jan 21, 2026 109.19 111.97 108.73 111.11 109.49 12,844,383
Jan 20, 2026 108.11 109.64 106.93 109.45 107.85 15,241,138
Jan 16, 2026 110.72 110.73 108.43 108.83 107.24 14,852,069
Jan 15, 2026 110.62 111.58 108.45 110.97 109.35 11,775,844
Jan 14, 2026 108.97 111.22 107.95 111.01 109.39 11,964,625
Jan 13, 2026 109.05 109.31 107.22 108.26 106.68 9,338,579
Jan 12, 2026 110.97 111.46 108.78 109.19 107.60 10,671,910
Jan 9, 2026 110.87 112.48 110.22 110.53 108.92 11,040,798
Jan 8, 2026 110.61 112.90 109.25 110.99 109.37 20,278,830
Jan 7, 2026 109.50 111.46 107.95 108.60 107.01 16,322,345
Jan 6, 2026 107.68 110.17 107.68 108.87 107.28 14,478,957
Jan 5, 2026 107.01 108.44 105.80 107.44 105.87 15,863,319
Jan 2, 2026 105.53 106.62 104.43 106.45 104.90 9,992,435
Dec 31, 2025 105.94 106.10 104.99 105.26 103.72 7,557,325
Dec 30, 2025 106.73 106.88 105.64 106.06 104.51 6,498,303
Dec 29, 2025 106.85 107.59 106.42 106.62 105.06 8,086,890
Dec 26, 2025 106.45 107.05 106.03 106.78 105.22 6,280,701
Dec 24, 2025 105.36 106.95 105.28 106.45 104.90 5,335,048
Dec 23, 2025 104.56 105.39 104.33 105.04 103.51 13,587,456
Dec 22, 2025 100.63 104.95 100.40 104.72 103.19 17,136,247
Dec 19, 2025 100.60 102.19 100.11 101.09 99.61 44,980,247
Dec 18, 2025 99.27 101.37 98.86 100.69 99.22 14,312,767
Dec 17, 2025 98.18 100.14 98.06 99.18 97.73 13,180,992
Dec 16, 2025 100.30 100.34 96.79 98.27 96.83 16,663,614
Dec 15, 2025$0.85 dividend 99.99 100.94 98.00 100.26 98.80 16,735,873
Dec 12, 2025 98.96 100.66 98.31 100.30 98.00 11,810,788
Dec 11, 2025 98.44 99.14 97.58 99.01 96.74 11,808,178
Dec 10, 2025 98.05 98.17 96.47 97.62 95.39 18,077,712
Dec 9, 2025 99.32 99.85 96.06 96.89 94.67 16,283,945
Dec 8, 2025 99.38 99.67 97.81 98.93 96.67 12,902,587
Dec 5, 2025 101.40 102.09 99.19 99.72 97.44 16,430,388
Dec 4, 2025 102.10 102.60 100.54 100.89 98.58 12,770,712
Dec 3, 2025 101.89 103.09 101.52 102.27 99.93 12,541,641
Dec 2, 2025 101.53 101.80 100.31 101.03 98.72 11,794,980
Dec 1, 2025 104.72 105.68 101.71 101.83 99.50 14,178,308
Nov 28, 2025 104.83 105.41 104.12 104.83 102.43 6,154,508
Nov 26, 2025 104.59 105.75 104.20 104.63 102.24 12,624,017
Nov 25, 2025 100.73 105.84 100.70 105.66 103.24 22,225,531
Nov 24, 2025 99.12 102.36 99.12 100.40 98.10 28,320,935
Nov 21, 2025 95.48 100.27 95.36 97.76 95.52 23,183,284
Nov 20, 2025 94.97 96.00 93.90 94.97 92.80 12,554,217
Nov 19, 2025 96.00 97.14 94.09 95.05 92.88 14,641,308
Nov 18, 2025 94.11 97.66 92.11 96.43 94.22 28,153,549
Nov 17, 2025 93.23 94.75 92.67 92.86 90.73 14,345,822
Nov 14, 2025 92.20 95.08 91.49 92.92 90.79 19,632,021
Nov 13, 2025 91.31 94.26 90.90 92.93 90.80 16,086,082
Nov 12, 2025 91.41 92.91 91.16 91.45 89.36 13,218,933
Nov 11, 2025 87.35 91.06 87.26 90.95 88.87 15,436,039
Nov 10, 2025 86.69 87.37 85.80 86.75 84.77 8,319,573
Nov 7, 2025 85.95 86.58 85.24 86.28 84.31 9,214,301
Nov 6, 2025 84.48 86.17 84.35 85.78 83.82 10,601,445
Nov 5, 2025 84.03 85.38 82.91 84.39 82.46 9,440,157
Nov 4, 2025 82.70 84.96 82.01 83.86 81.94 12,846,087
Nov 3, 2025 85.77 86.10 82.34 82.49 80.60 13,875,806
Oct 31, 2025 85.42 86.46 84.56 85.98 84.01 12,384,986
Oct 30, 2025 84.62 87.30 83.30 86.28 84.31 16,678,844
Oct 29, 2025 86.94 87.84 86.07 86.58 84.60 10,921,908
Oct 28, 2025 88.11 88.11 86.93 87.03 85.04 8,345,943
Oct 27, 2025 87.51 88.30 87.03 88.00 85.99 7,226,555
Oct 24, 2025 87.33 88.06 87.11 87.49 85.49 7,902,072
Oct 23, 2025 87.56 88.11 86.91 87.18 85.19 7,687,450
Oct 22, 2025 87.68 88.79 87.01 87.61 85.61 10,926,343
Oct 21, 2025 86.96 87.67 86.23 87.62 85.61 9,852,403
Oct 20, 2025 85.25 87.00 85.03 86.32 84.34 8,611,782
Oct 17, 2025 83.28 84.89 83.16 84.79 82.85 10,758,923
Oct 16, 2025 84.41 85.50 83.60 83.92 82.00 11,709,057
Oct 15, 2025 84.19 84.69 83.61 84.11 82.19 9,168,705
Oct 14, 2025 85.38 85.68 84.15 84.70 82.76 9,675,036
Oct 13, 2025 85.66 86.46 85.24 85.70 83.74 6,553,942
Oct 10, 2025 87.94 88.24 85.92 85.99 84.02 11,230,694
Oct 9, 2025 86.96 87.80 86.64 87.50 85.50 10,938,196
Oct 8, 2025 87.93 87.93 86.20 86.40 84.42 9,696,200
Oct 7, 2025 88.67 88.94 87.14 87.61 85.61 9,449,085
Oct 6, 2025 88.83 90.31 88.55 88.80 86.77 11,648,298
Oct 3, 2025 89.62 90.70 88.10 89.19 87.15 12,970,576
Oct 2, 2025 89.95 91.00 88.22 89.51 87.46 14,575,377
Oct 1, 2025 85.19 90.75 85.19 90.13 88.07 33,460,875
Sep 30, 2025 78.42 84.00 78.39 83.93 82.01 21,636,633
Sep 29, 2025 78.60 78.80 78.03 78.58 76.78 12,739,027
Sep 26, 2025 78.76 78.96 77.69 78.56 76.76 12,234,989
Sep 25, 2025 79.78 79.88 77.58 77.60 75.82 14,923,787
Sep 24, 2025 79.90 80.11 79.33 79.67 77.85 11,804,178

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Merck & Co., Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at MRK, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation